2 Best Pharma Stocks to Buy in November
The two pharma stocks offer investors the upside of a coronavirus vaccine with the peace of mind of century-old businesses.
Mylan(MYL)
NASDAQ
MYL
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
Interactive Chart
News & Analysis: Mylan
The Fool has written over 200 articles on Mylan.
3 Reasons Pfizer's Imminent Upjohn-Mylan Merger Is Great News for Investors
There really isn't a downside to this deal.
Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit
The Federal Trade Commission has signed off on the deal.
FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
The agency found no evidence to support the theory that the antimalarial drugs touted by President Trump are effective against the coronavirus.
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Cheaper insulin is on its way.
3 Drug Stocks That Could Soar in 2020
Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
Gilead Strikes Deal With Mylan to Supply Remdesivir Internationally
Mylan will distribute the drug as a COVID-19 treatment in 127 low- and middle-income countries.
What's Behind Mylan's Mixed Q1 Results
The COVID-19 pandemic helped the drugmaker's sales more than it hurt.
FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet
Regulators take different approaches to the unapproved medications.
